Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would reduce bleeding complications without compromising the rate of ischemic events compared to heparin plus GP IIb/IIIa inh...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bentham Open
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002443/ |